Low molecular weight heparin assay, system and reagent therefor

Details for Australian Patent Application No. 2002346695 (hide)

Owner CARDIOVASCULAR DIAGNOSTIC, INC.

Inventors Mize, Patrick D

Agent Pizzeys

Pub. Number AU-A-2002346695

PCT Number PCT/US02/39308

PCT Pub. Number WO2003/050298

Priority 10/004,791 07.12.01 US

Filing date 9 December 2002

Wipo publication date 23 June 2003

International Classifications

C12Q 001/37 Measuring or testing processes involving enzymes or micro-organisms - involving peptidase or proteinase

G01N 033/86 Investigating or analysing materials by specific methods not covered by groups - involving blood coagulating time

Event Publications

13 March 2003 Complete Application Filed

  Priority application(s): 10/004,791 07.12.01 US

28 August 2003 Application Open to Public Inspection

  Published as AU-A-2002346695

3 July 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002346696-GLUCOSAMINE ORGANIC ACID ADDUCTS

2002346694-AMORPHOUS FORM OF 2-N-BUTYL-3-( (2-(1H-TETRAZOL-5-YL) (1,1'-BIPHENYL)-4-YL) METHYL) - 1,3-DIAZASPIRO (4,4') NON1-EN-4-ONE